Right vEntricular Dysfunction in tEtralogy of Fallot: INhibition of the rEnin-angiotensin-aldosterone system (REDEFINE) trial: Rationale and design of a randomized, double-blind, placebo-controlled clinical trial

The REDEFINE trial will study the effects of RAAS inhibition with losartan in TOF patients with RV dysfunction.